Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
A systematic review and meta-analysis synthesizes results from 12 eligible animal studies on salidroside treatment for non-alcoholic fatty liver disease. The analysis, conducted by Shuai Li and published in 2026, evaluates therapeutic effects on outcomes like hepatic triglycerides, liver enzymes, and inflammatory markers. It provides statistical measures including standardized mean differences for numerous biochemical and histological indicators.
Data is presented as a summary document (DOCX format) of the meta-analysis, not as a structured dataset of individual study results. The CC-BY-4.0 license applies to this document.